Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Connect your AI · Plans and the 7-day free trial (card required)

Buying vs selling by year

Estimated dollars bought and sold each year, based on the ranges members disclose.

Loading…

Committees

The congressional committees and subcommittees this member sits on.

We list committee seats for current members only.

Campaign money

What this member's campaign committees raised and spent in the latest election cycle, from reports filed with the Federal Election Commission.

Campaign money, latest election cycle
RaisedSpentCash on handDebts
$3,580$36,908$19,760—

2026 cycle (January 2025 to December 2026), reports through Sep 30, 2026. Candidate page on FEC.gov ↗

2024 cycle: raised $1,053, spent $24.9K, cash on hand $53.1K. FEC.gov ↗

Totals for the whole two-year cycle, not one election. Raised includes transfers between a candidate's own committees. Totals only: no individual donor is named or shown.

Net worth

2019 report

An estimate from the member's annual financial disclosure, as a range. The form reports value ranges, not exact figures.

Low
$7.0M
Middle (midpoint estimate) The form reports value brackets, not exact figures. Low counts every asset at the bottom of its bracket and every debt at the top; high is the reverse; the middle (midpoint estimate) uses the middle of every bracket. The range is wide because it adds up every bracket.
$13.3M
High
$19.6M

From the 2019 annual report: 290 assets and 0 liabilities listed. The range is wide because every asset and debt is counted at the lowest and highest end of its bracket.

Estimated net worth by report year
The form reports value brackets, not exact figures. Low counts every asset at the bottom of its bracket and every debt at the top; high is the reverse; the middle (midpoint estimate) uses the middle of every bracket. The range is wide because it adds up every bracket.Report
2019$7.0M$13.3M$19.6M2900PDF ↗
2018$6.3M$12.4M$18.5M2270PDF ↗
2017$6.3M$12.4M$18.4M2390PDF ↗
2015$5.0M$11.3M$17.7M4930Amendment PDF ↗

Estimated from the member's annual disclosure: assets minus liabilities, using the reported value ranges. Excludes the primary residence. Not audited.

Trades

Every trade this member, their spouse or dependent children have disclosed, newest first unless you sort by another column.

Disclosed trades
StockAsset typeTransactionFiledTradedSince tradeHow the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.CommentFiling
OXY
Occidental Petroleum Corporation
—Sale
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 5, 2017Sep 22, 2017—PDF ↗
MET
MetLife, Inc.
—Sale
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 5, 2017Sep 22, 2017—PDF ↗
XOM
ExxonMobil Holdings Corporation
—Sale
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 5, 2017Sep 22, 2017—PDF ↗
BNS
bank Nova Scotia Halifax Pfd 3 Ordinary Shares (BNS)
—Purchase
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 5, 2017Sep 22, 2017—PDF ↗
SP500 Arn Issuer bOFA Cap 10.00% SV 2,415.07 Due 07/27/18—Purchase
$50,001 - $100,000
Spouse
SP M40 (Merrill Lynch)
Oct 5, 2017Sep 21, 2017—SP500 ARN ISSUER bOFA CAP 10.00% SV 2,415.07 DUE 07/27/18PDF ↗
SX5E Stepup Issuer bAC Step 27.90% SV 3,044.33 Due 11/26/18—Purchase
$50,001 - $100,000
Spouse
SP M40 (Merrill Lynch)
Oct 5, 2017Sep 19, 2017—SX5E STEPUP ISSUER bAC STEP 27.90% SV 3,044.33 DUE 11/26/18PDF ↗
SP500 Arn Issuer bOFA Cap 10.00% SV 2,388.77 Due 06/29/18—Purchase
$50,001 - $100,000
Spouse
SP M40 (Merrill Lynch)
Oct 5, 2017Sep 19, 2017—SP500 ARN ISSUER bOFA CAP 10.00% SV 2,388.77 DUE 06/29/18PDF ↗
Du Pont E I de Nemours Pay Date 09/01/2017—Exchange
$15,001 - $50,000
Spouse
SP M81 (Merrill Lynch)
Oct 5, 2017Sep 1, 2017—DU PONT E I DE NEMOURS PAY DATE 09/01/2017PDF ↗
Dowdupont Inc Com Pay Date 09/01/2017—Exchange
$15,001 - $50,000
Spouse
SP M81 (Merrill Lynch)
Oct 5, 2017Sep 1, 2017—DOWDUPONT INC COM PAY DATE 09/01/2017PDF ↗
Rio gRANDE City Tex Cons Isd Ser b RF PSF gTD Oid OCT15 03.500%AUg15 2037—Purchase
$50,001 - $100,000
Spouse
SP M40 (Merrill Lynch)
Oct 4, 2017Aug 28, 2017—RIO gRANDE CITY TEX CONS ISD SER b RF PSF gTD OID OCT15 03.500%AUg15 2037PDF ↗
SX5E Stepup Issuer HSbC Step 30.00% SV 3,280.78 Due 08/31/18—Sale
$15,001 - $50,000
Spouse
SP M37 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—SX5E STEPUP ISSUER HSbC STEP 30.00% SV 3,280.78 DUE 08/31/18 RedemptionPDF ↗
SP500 Clirn Issuer bAC Cap 14.54% SV 1,987.66 Due 08/25/17—Sale
$100,001 - $250,000
Spouse
Trust M69 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—SP500 CLIRN ISSUER bAC CAP 14.54% SV 1,987.66 DUE 08/25/17 ExchangePDF ↗
SP500 Clirn Issuer bAC Cap 14.54% SV 1,987.66 Due 08/25/17—Sale
$15,001 - $50,000
Spouse
SP M37 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—SP500 CLIRN ISSUER bAC CAP 14.54% SV 1,987.66 DUE 08/25/17 RedemptionPDF ↗
SP500 Clirn Issuer bAC Cap 14.54% SV 1,987.66 Due 08/25/17—Sale
$100,001 - $250,000
Spouse
SP M40 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—SP500 CLIRN ISSUER bAC CAP 14.54% SV 1,987.66 DUE 08/25/17 RedemptionPDF ↗
SP500 Clirn Issuer bAC Cap 14.04% SV 2,089.41 Due 10/27/17—Sale
$100,001 - $250,000
Spouse
SP M40 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—SP500 CLIRN ISSUER bAC CAP 14.04% SV 2,089.41 DUE 10/27/17PDF ↗
PM
Philip Morris International Inc
—Purchase
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—PDF ↗
CVS
CVS Health Corporation
—Sale
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—PDF ↗
KO
Coca-Cola Company
—Purchase
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 4, 2017Aug 25, 2017—PDF ↗
SX5E Stepup Issuer HSbC Step 40.00% SV 3,444.73 Due 08/25/22—Purchase
$50,001 - $100,000
Spouse
Trust M69 (Merrill Lynch)
Oct 4, 2017Aug 24, 2017—SX5E STEPUP ISSUER HSbC STEP 40.00% SV 3,444.73 DUE 08/25/22PDF ↗
SX5E Stepup Issuer HSbC Step 40.00% SV 3,444.73 Due 08/25/22—Purchase
$50,001 - $100,000
Spouse
SP M40 (Merrill Lynch)
Oct 4, 2017Aug 24, 2017—SX5E STEPUP ISSUER HSbC STEP 40.00% SV 3,444.73 DUE 08/25/22PDF ↗
SX5E Clirn Issuer CS Cap 25.65% SV 3,444.73 Due 08/30/19—Purchase
$50,001 - $100,000
Spouse
Trust M69 (Merrill Lynch)
Oct 4, 2017Aug 24, 2017—SX5E CLIRN ISSUER CS CAP 25.65% SV 3,444.73 DUE 08/30/19PDF ↗
SX5E Clirn Issuer CS Cap 25.65% SV 3,444.73 Due 08/30/19—Purchase
$50,001 - $100,000
Spouse
SP M40 (Merrill Lynch)
Oct 4, 2017Aug 24, 2017—SX5E CLIRN ISSUER CS CAP 25.65% SV 3,444.73 DUE 08/30/19PDF ↗
PM
Philip Morris International Inc
—Purchase
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 4, 2017Aug 24, 2017—PDF ↗
CVS
CVS Health Corporation
—Sale
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 4, 2017Aug 24, 2017—PDF ↗
KO
Coca-Cola Company
—Purchase
$1,001 - $15,000
Spouse
SP M81 (Merrill Lynch)
Oct 4, 2017Aug 24, 2017—PDF ↗

Returns describe the stock since the trade date, not the member’s actual result. Information, not investment advice.

Trades in companies under their committees' jurisdiction

Trades in a company whose industry falls under a committee or subcommittee this member sits on.

Loading…

Capitol Hires from K. Michael Conaway’s office

16 hires

Lobbyists for public companies who say they once worked in K. Michael Conaway’s office, from their lobbying filings.

Capitol Hires from K. Michael Conaway's office
The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them.
OXY
Occidental Petroleum Corporation
Jeff BurtonChief of StaffBurton Strategy Group
Report period 2026 Q3 ↗
Posted Oct 26, 2026 · in 8 filings
GAP
Gap, Inc.
Mark WilliamsChief of StaffFerox Strategies
Report period 2026 Q3 ↗
Posted Oct 19, 2026
FTNT
Fortinet, Inc.
Sarah (Beatty) RogersSr. Legislative AssistantNavigators Global LLC (formerly DC Navigators, LLC)
Report period 2026 Q1 ↗
Posted Apr 21, 2026 · in 2 filings
APTV
Aptiv plc
Mark WilliamsChief of StaffFerox Strategies
Report period 2026 Q1 ↗
Posted Apr 20, 2026 · in 2 filings
RNA
Atrium Therapeutics, Inc.
Mark WilliamsChief of StaffFerox Strategies
Report period 2026 Q1 ↗
Posted Apr 17, 2026 · in 2 filings

Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered.

Bills sponsored

The ten most recent bills and resolutions this member introduced.

No recent sponsored bills for this member. We list sponsored bills for current members only.

Recent votes

The latest recorded votes this member took part in, with how they voted.

Loading…

Terms served

Each term in office, with the seat and party at the time.

Terms served
Jan 3, 2019Jan 3, 2021HouseTX-11Republican
Jan 3, 2017Jan 3, 2019HouseTX-11Republican
Jan 6, 2015Jan 3, 2017HouseTX-11Republican
Jan 3, 2013Jan 3, 2015HouseTX-11Republican
Jan 5, 2011Jan 3, 2013HouseTX-11Republican
Jan 6, 2009Jan 3, 2011HouseTX-11Republican
Jan 4, 2007Jan 3, 2009HouseTX-11Republican
Jan 4, 2005Jan 3, 2007HouseTX-11Republican

← All members of Congress